Correction to: Molecular detection and clinicopathological characteristics of advanced/recurrent biliary tract carcinomas harboring the FGFR2 rearrangements: a prospective observational study (PRELUDE Study)
1 Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
2 Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. cmorizan@ncc.go.jp.
3 Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan.
4 Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
5 Department of Gastroenterology, Hepatobiliary and Pancreatic Medical Oncology Division, Kanagawa Cancer Center, Kanagawa, Japan.
6 Department of Oncology Center, Yamaguchi University Hospital, Yamaguchi, Japan.
7 Department of Gastroenterology, National Hospital Organization Takasaki General Medical Center, Gunma, Japan.
8 Department of Hepato-Biliary-Pancreatology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
9 Department of Gastroenterology, Aichi Cancer Center Hospital, Aichi, Japan.
10 Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan.
11 Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
12 Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
13 Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, Ehime, Japan.
14 Department of Gastroenterology, Saitama Cancer Center, Saitama, Japan.
15 Department of Surgery, National Hospital Organization Osaka National Hospital, Osaka, Japan.
16 Department of Medical Oncology, Tochigi Cancer Center, Tochigi, Japan.
17 Department of Gastroenterology, Kofu Municipal Hospital, Yamanashi, Japan.
18 Department of Gastroenterology, National Center for Global Health and Medicine, Tokyo, Japan.
19 Department of Medical Oncology, Kyorin University Faculty of Medicine, Tokyo, Japan.
20 Department of Clinical Oncology, St.Marianna University School of Medicine, Kanagawa, Japan.
21 Kyoto Innovation Center for Next Generation Clinical Trials and iPS Cell Therapy, Kyoto University Hospital, Kyoto, Japan.
22 Division of Gastroenterology, Chiba Cancer Center, Chiba, Japan.
23 Department of Oncology Division, Yokohama City University School of Medicine, Kanagawa, Japan.
24 Department of Biostatistics, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.